Ontong, Baby Boy .
HRN: 25-69-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/15/2024
08/22/2024
IV
20
Q24h
Noninstitutional Delivery
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes